Exhibit
99.2







FOR IMMEDIATE
RELEASE





Contact:                Judy
Zakreski


Lawrence Pemble


(301) 215-7777





CHINDEX
INTERNATIONAL ANNOUNCES SHELF REGISTRATION,


RELATED
STRATEGY AND GUIDANCE




BETHESDA,
MARYLAND  –  May 13,
2008  –  Chindex International, Inc. (NASDAQ: CHDX),
a leading independent American provider of Western healthcare services and
products in the People’s Republic of China, announced
that it has filed a shelf registration statement with the Securities and
Exchange Commission (SEC) that, if declared effective by the SEC, would allow
the Company to sell, from time to time, up to $100 million of its common stock
or related securities in one or more offerings. While the Company does not have
any present intention to use the shelf registration statement, it is intended to
give Chindex greater flexibility to take advantage of favorable market
conditions and to respond to strategic opportunities as they may arise. The
Company is not required to offer or sell any securities under the shelf
registration statement and will consider, to the extent practicable, offerings
that would not be dilutive to stockholders.  The terms of any offering
under the shelf registration statement will be established at the time of the
offering.




In
connection with the filing, Roberta Lipson, the Company’s Chief Executive
Officer, elaborated on the related strategy: “Here in China, the healthcare
industry continues to grow rapidly in many different ways. We recently completed
financings with J.P. Morgan, the International Finance Corporation and DEG –
Deutsche Investitions toward two new hospital facilities. These projects, which
are moving forward and whose progress will be updated periodically, will support
the Company’s growth and represent the kind of expansion opportunities that we
believe will allow us to exploit the rapid growth of the healthcare business in
China.




“In
addition, from time to time numerous other opportunities present themselves as
prospective drivers of further growth in our industry.  We need to be
properly positioned and prepared to respond nimbly to these strategic
opportunities, such as potential acquisitions and venture projects. Accordingly,
as we have noted, the shelf registration statement is intended to give us
greater flexibility to take advantage of favorable market conditions and to
quickly respond to these strategic opportunities.




“Separately,
today we announced that our earnings call for last fiscal year, ended March 31,
2008, will be held on June 12, at which time we will report strong overall
results for that year. Looking forward in the current fiscal year 2009, we
currently believe that our hospital division will achieve an approximately 30%
increase over last fiscal year’s revenues, with continuing improvement of
operating income as a percentage of revenue. Our medical products division had a
disappointing 2008 fiscal year and final quarter primarily due to persisting
delays in product registrations, which are subject to Chinese Governmental
bureaucratic approval practices, and some of which have been in process for well
over a year. Subject to the receipt of these approvals and the execution of
an







increased
number of U.S. and German Government-backed loan projects, we expect the medical
products division to return to profitability in the current year.”




The shelf
registration statement has not yet become effective. The securities offered by
the Company under the shelf registration statement may not be sold, nor may
offers to buy the securities be accepted prior to the time the registration
statement becomes effective. This press release shall not constitute an offer to
sell or the solicitation of an offer to buy, nor shall there be any sale of any
securities in any jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of
any such jurisdiction. Any offering may be made only by means of prospectus and
a related prospectus supplement.




If
declared effective by the SEC, the shelf registration statement would enable
Chindex to raise funds from the offering through underwriters, agents, dealers
or by sales to direct purchasers, subject to market conditions and the Company’s
capital needs.  The proceeds from the primary sales of securities by
the Company under the shelf registration statement will be used for the purposes
described in a prospectus supplement filed at the time of an
offering.




About Chindex International,
Inc.





Chindex
is an American healthcare company that provides healthcare services and supplies
medical capital equipment, instrumentation and products to the Chinese
marketplace, including Hong Kong. It provides healthcare services through the
operations of its United Family Hospitals and Clinics, a network of private
primary care hospitals and affiliated ambulatory clinics in China. The Company’s
hospital network currently operates in the Beijing and Shanghai metropolitan
areas. The Company sells medical products manufactured by various major
multinational companies, including Siemens AG and Intuitive Surgical, which are
the Company’s exclusive distribution partners for the sale and servicing of
color doppler ultrasound systems and robotic surgical systems respectively. It
also arranges financing packages for the supply of medical products to hospitals
in China utilizing the export loan and loan guarantee programs of both the U.S.
Export-Import Bank and the German KfW Development Bank. With twenty-six years of
experience, over 1,000 employees, operations in mainland China and Hong Kong,
offices in the United States and Germany, the Company’s strategy is to expand
its cross-cultural reach by providing leading edge healthcare technologies,
quality products and services to Greater China's professional communities.
Further company information may be found at the Company’s websites,
www.chindex.com and www.unitedfamilyhospitals.com.




Statements
made in this press release relating to plans, strategies, objectives, economic
performance and trends and other statements that are not descriptions of
historical facts may be forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended (the “Securities Act”), and
Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”). Forward-looking information is inherently subject to risks and
uncertainties, and actual results could differ materially from those currently
anticipated due to a number of factors, which include, but are not limited to,
the factors set forth under the heading “Risk Factors” in our annual report on
Form 10-K for the year ended March 31, 2007, updates and additions to those
“Risk Factors” in our interim reports on Form 10-Q, Forms 8-K and in other
documents filed by us with the Securities and Exchange Commission from time to
time. In particular, forward-looking statements made in this press release are
subject to risks and uncertainties such that there can be no assurances
whatsoever: that the shelf registration statement will be declared effective or
that if so will not require further filings with or accelerations by the SEC;
that the healthcare business in China will continue to grow at recent or other
anticipated rates; that any strategic opportunities will become available to the
Company or, if pursued, will prove to be successful; that the shelf registration
statement will provide actual benefits to the Company in achieving any such
opportunities or such





success;
that any offering under the shelf registration statement will be consummated
without dilution to stockholders; that the revenues or operating income as a
percentage of revenues of the hospital division will increase in the amounts
anticipated if at all; that either Chinese Governmental approval processes
regarding our product registrations or U.S. and German government-backed loan
projects will be successfully completed or lead to profitable product sales; nor
that the medical products division
will return to profitability in the current year.Forward-looking
statements may be identified by terms such as “may”, “will”, “should”, “could”,
“expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”,
“predicts”, “forecasts”, “potential”, or “continue” or similar terms or the
negative of these terms. Although we believe that the expectations reflected in
the forward-looking statements are reasonable, we cannot guarantee future
results, levels of activity, performance or achievements. We have no obligation
to update these forward-looking statements